{"auto_keywords": [{"score": 0.05007852962010532, "phrase": "principal_component_analysis"}, {"score": 0.004349337717774093, "phrase": "latent_variable_models"}, {"score": 0.004081832864946222, "phrase": "pca"}, {"score": 0.0038789122930433305, "phrase": "robust_alternative"}, {"score": 0.00378145978325955, "phrase": "pharmacokinetic_modeling"}, {"score": 0.003503497128638099, "phrase": "dynamic_contrast-enhanced_magnetic_resonance_images"}, {"score": 0.0031242709509664837, "phrase": "oncological_studies"}, {"score": 0.0030457198309616694, "phrase": "theoretical_and_practical_justifications"}, {"score": 0.002750721367040336, "phrase": "pca_approach"}, {"score": 0.0026475981474045414, "phrase": "pilot_study"}, {"score": 0.0025810006125483835, "phrase": "clinical_dce-mri_data"}, {"score": 0.0021049977753042253, "phrase": "john_wiley"}], "paper_keywords": ["DCE-MRI", " multivariate image analysis (MIA)", " PCA", " latent variable modeling (LVM)", " oncology"], "paper_abstract": "This paper proposes the use of latent variable models based on principal component analysis (PCA) as a robust alternative to pharmacokinetic modeling for the analysis of the dynamic contrast-enhanced magnetic resonance images (DCE-MRI) often obtained during oncological studies. Theoretical and practical justifications are provided for the advantages of the PCA approach. A pilot study using clinical DCE-MRI data on prostate patients is presented to demonstrate the method. Copyright (C) 2008 John Wiley & Sons, Ltd.", "paper_title": "Dynamic contrast-enhanced MRI diagnostics in oncology via principal component analysis", "paper_id": "WOS:000262017500019"}